Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083

By sjmartinez • November 24, 2024

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF, Jennings A, Gomez-Feliciano K, McCauley M, Grinsztejn B, Landovitz RJ; for HPTN 083 Study Team. Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083. Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093/cid/ciae572. Epub ahead of print. PMID: 39579334.

Tags: bacterial sexually transmitted infections, CAB-LA, efficacy, HIV prevention, Infectious Diseases, Long-acting PrEP, Publications

Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes

Sundar KG, Yang LZ, Cambou MC, Varella IRS, Melo MG, Segura ER, Ziegler ÂP, Santos BR, Nielsen-Saines K. Prompt Initiation of Maternal Antiretroviral Therapy After[...]

Factors Associated With PrEP Utilization and Access in the United States

David HM, Martin T, Wells A, Little SJ, Mehta S. Factors Associated With PrEP Utilization and Access in the United States. AIDS Educ Prev. 2024[...]

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.